Mark Bodmer - CEO @ Nucleome Therapeutics - Crunchbase Person Profile

Overview

CB Rank (Person)

Primary Job Title CEO
Primary Organization
Nucleome Therapeutics

Location Oxford, Oxfordshire, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

LinkedIn View on LinkedIn

Mark Bodmer is based out of Oxford, Oxfordshire and is the CEO of Nucleome Therapeutics. Mark previously worked at Evelo Biosciences as a CSO. Mark Bodmer attended the University of Cambridge.

Jobs

Number of Current Jobs

Number of Past Jobs

Mark Bodmer

is the

CEO

Nucleome Therapeutics

. Additionally,

Mark Bodmer

has had

past job as the

CSO

Evelo Biosciences

Nucleome Therapeutics CEOJul 24, 2024

Organization Name	Title At Company	Start Date	End Date
Evelo Biosciences	CSO	Apr 2016	Feb 2024

Related Hubs

Hub Name	CB Rank (Hub)
Genetics Companies With More Than 10 Employees	29,824
Europe, Middle East, and Africa (EMEA) Early Stage Companies With Fewer Than 50 Employees	20,543
Biotechnology Early Stage Companies With Less Than $1B in Revenue	33,024
Pfizer Venture Investments Portfolio Companies	58,813
Therapeutics Companies With Less Than $50M in Revenue (Top 10K)	11,171
United Kingdom Therapeutics Companies	23,303
Europe Startups Founded in 2019	27,445
Genetics Companies with Early Stage Venture Funding	74,362
Therapeutics Early Stage Companies With Less Than $1B in Revenue	60,904
Biotechnology Early Stage Companies With Fewer Than 100 Employees	30,101